This review aims to provide an overview and update on the current knowledge of acute (spontaneous) urticaria (AU) and chronic spontaneous urticaria (CSU), the underlying mechanisms that drive AU progression to CSU and remission, and characterize the existing knowledge gap. A summary of current and prospective treatment...
M. Afshar-Bakshloo, L. M. Böhm, E. Kruger et al.· Current Treatment Options in...· 0 citations
In this post hoc analysis funded by AstraZeneca, benralizumab reduced eosinophil‐related protein biomarker expression.
Benralizumab reduced eosinophil‐derived neurotoxin concentrations, which were dose‐independent and irrespective of BHRA status.
E. Rodríguez-Suárez, M. Cardner, D. Muthas et al.· Clinical and Experimental Al...· 0 citations
Chronic urticaria is a mast cell-driven inflammatory disease characterized by recurrent wheals, angioedema or both for more than 6 weeks, with substantial effects on sleep, quality of life, mental health and daily functioning. Type I autoallergic and type IIb autoimmune mechanisms represent major endotypes, but many pa...
A. Salman, M. Al-Ahmad, M. Al-Nesf et al.· Journal of the European Acad...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.